New stock news | New G pharmaceuticals, Yifei Technology, and others plan for Hong Kong IPO have been accepted by China Securities Regulatory Commission.

On January 30th, the China Securities Regulatory Commission released the "Domestic Enterprises Overseas Securities Issuance and Listing Filing Status Table (Initial Public Offering and Full Circulation) (as of January 30, 2026)", in which XinJi Pharmaceutical, Yifei Technology, Daoyuan Technology, CarLink World, Weimai Medical, Shenzhen Kinwong Electronic, Junsai Biology, and Zhuxian Technology plan to submit materials for Hong Kong IPO to the China Securities Regulatory Commission; Laoxiang Chicken (indirect overseas listing) intends to seek opinions for Hong Kong IPO filing status; Ximai Semiconductor intends to supplement materials for Hong Kong IPO filing status.